How much is the cost difference between second-generation and third-generation IVF in Georgia? Real price comparison and decision reference

Direct answer: The cost gap between second-generation and third-generation IVF in Georgia

The total cost of a complete cycle of second-generation IVF (Intracytoplasmic Sperm Injection, ICSI) in Georgia is typically between $8,000 and $12,000; the cost of third-generation IVF (ICSI + Preimplantation Genetic Testing, PGT) is concentrated between $12,000 and $18,000. The difference mainly comes from:

Laboratory fees for embryo genetic testing (PGT-A or PGT-M) (approximately $3,000 to $5,000 per cycle);
Embryo biopsy procedure fees;
Additional embryo freezing and storage costs due to testing.

It is important to note that specific costs vary individually depending on the pricing strategy of the reproductive center, patient age, type of test required (PGT-A screening for aneuploidy vs. PGT-M diagnosis for monogenic diseases), medication dosage, and whether egg/sperm donation is involved.

Why does this price difference exist? — Breakdown of cost composition

To understand the price difference, first clarify the core distinction between second and third generation:

Item	Second-generation IVF (ICSI)	Third-generation IVF (PGT)
Core steps	Ovarian stimulation, egg retrieval, ICSI fertilization, embryo culture for 3-6 days	ICSI plus embryo biopsy + genetic testing
Genetic testing	None	PGT-A or PGT-M (biopsy fee + testing fee charged separately)
Number of frozen embryos	Usually freeze 2-5	Only some embryos are eligible after testing; fewer are frozen, but freezing fees are charged per year or per straw
Cycle length	Approximately 4-6 weeks	Approximately 6-8 weeks (due to waiting for test results)

The most decisive difference: PGT testing requires amplification and analysis of 5-10 trophectoderm cells after blastocyst biopsy. PGT-A (aneuploidy screening) costs about $2,000 to $3,000, and PGT-M (monogenic disease diagnosis) costs about $3,500 to $5,000. If both PGT-A and PGT-M are performed simultaneously, the testing fee will be cumulative. Adding the embryo biopsy procedure fee (approximately $1,000 to $1,500), the total cost of third-generation is directly 40% to 60% higher than second-generation.

What do doctors think? — Cost considerations in clinical decision-making

Reproductive specialists recommend third-generation IVF based on the specific circumstances of the couple:

Who is suitable for third-generation IVF? Women over 38 years old (increased risk of chromosomal aneuploidy), recurrent implantation failure (≥2 times), recurrent miscarriage (≥2 times), known chromosomal structural abnormalities in one partner (e.g., balanced translocation) or carriers of monogenic genetic diseases, and sex-linked genetic diseases requiring embryo sex selection.
Who is not suitable for direct third-generation IVF? For tubal factor infertility, mild male oligoasthenospermia (unless combined with other indications), and first IVF cycles in young women without a genetic history, doctors usually recommend trying second-generation IVF first. This is because PGT itself carries a very low risk of biopsy damage and may lead to the discarding of some embryos, increasing the probability of having fewer transferable embryos per cycle.

Doctors emphasize: Do not blindly choose third-generation for "extra assurance"; it is important to match medical indications. If the embryo attrition rate from third-generation is too high (e.g., low blastocyst formation rate in older patients), it may paradoxically reduce the cumulative live birth rate.

Impact of age on cost differences

Age directly affects the dosage of ovarian stimulation medication and the number of embryos, thereby influencing the total cost:

Under 35 years old: Good ovarian response, lower medication costs (about $1,500 to $2,500), usually yields more blastocysts. If doing third-generation, biopsy and testing fees are fixed, but the cost per embryo is relatively lower.
35 to 40 years old: Increased medication dosage (about $2,500 to $3,500), fewer eggs retrieved, lower blastocyst formation rate. Third-generation IVF may result in only 1-2 blastocysts available for biopsy; if all are abnormal after testing, no embryo is available for transfer, posing a higher risk of wasted costs.
Over 40 years old: May require multiple ovarian stimulation cycles to accumulate embryos, indirectly increasing total expenditure. Third-generation IVF has higher medical value in this age group (selecting normal embryos), but the cost per cycle may exceed $15,000.

Easily overlooked details

When comparing prices, many people only look at the "basic package fee" and ignore the following hidden costs:

Medication fees: Some centers in Georgia do not include ovarian stimulation medications in their quotes, requiring an additional $400 to $800 (short protocol) to $1,000 to $2,000 (long/antagonist protocol);
Freezing and storage fees: Third-generation IVF usually requires freezing embryos while waiting for test results. Freezing costs about $300 to $600 per year, charged per straw or per embryo;
Biopsy fee: Some institutions list the biopsy fee separately, around $1,200 to $1,500;
Embryo shipping fee: If the testing facility is different from the reproductive center (e.g., sending samples to an overseas lab), cold chain transportation may cost $300 to $500;
Multiple transfer fees: After third-generation screening, there are fewer eligible embryos. Although the success rate per transfer is slightly higher, if it fails, a new cycle must be started, and the package price no longer applies.

Common pitfalls

Based on practitioner observations, common mistakes users make include:

Confusing "PGT-A" with "PGT-M": PGT-A is cheaper but only screens for chromosomal number abnormalities (e.g., trisomy 21), not monogenic diseases; PGT-M is more expensive but can detect specific genetic diseases. Some institutions have vague pricing, leading users to think they are getting comprehensive testing when only PGT-A is done.
Blindly trusting "money-back guarantee" packages: A few clinics in Georgia offer "third-generation IVF success guarantee" packages (around $25,000), but they often come with strict conditions (e.g., age, AMH level, no refund after multiple failures). When reviewing terms, pay attention to whether embryo discard counts as a "failure."
Ignoring legal restrictions: Georgian law only allows medically necessary sex selection (i.e., for sex-linked genetic diseases). Doing third-generation for family balancing may violate local regulations. Some clinics operate illegally and face penalties, exposing patients to ethical risks.
Choosing third-generation without embryo grading assessment: If blastocyst grading is poor (grade C or more irregular), the normal rate after biopsy is very low, and biopsy may damage the embryo. It is recommended to obtain at least 2 usable blastocysts before considering biopsy.

Frequently asked questions

Q1: Which offers better value for money, second-generation or third-generation IVF in Georgia?

There is no absolute answer. From a medical perspective, for patients with clear indications (e.g., advanced age, recurrent miscarriage), third-generation IVF can reduce the number of failed transfers, indirectly saving costs on subsequent cycles. For young couples without genetic burdens, second-generation IVF can fully meet fertility needs, saving testing costs.

Q2: Does Georgia support third-party reproduction? What are the costs?

Georgian law allows commercial surrogacy and egg donation, but the total cost of third-generation IVF plus surrogacy is significantly higher (usually over $30,000). This article is limited to autologous cycles.

Q3: Can I do only PGT-A without PGT-M? What is the cost difference?

Yes. PGT-A costs about $2,000 to $3,000, and PGT-M costs about $3,500 to $5,000. If done together, testing fees may be cumulative, though some centers offer a package price (around $4,500 to $6,000).

Q4: Do Georgian quotes include medication and embryo freezing?

A few clinics offer "all-inclusive" packages, but most only cover ovarian stimulation, egg retrieval, lab procedures, and 3-5 transfers. Medications and freezing are charged separately. Request a detailed quote from the clinic and confirm each item.

Practitioner observations

As a coordinator who has assisted patients in connecting with Georgian reproductive centers for many years, I have noticed common decision-making errors:

Some users overemphasize the "screening advantage" of third-generation IVF while ignoring their insufficient embryo count. For example, a 35-year-old patient with AMH 0.8 ng/mL and 4-5 antral follicles insisted on third-generation, resulting in only 1 blastocyst, which was abnormal after biopsy. The entire cycle failed, costing over $15,000 with no embryo to transfer. If she had chosen second-generation IVF and attempted a fresh transfer, she might have succeeded.
Many users mistakenly believe that "third-generation IVF has a higher success rate." In reality, the improvement in live birth rate per single transfer is about 5% to 10% (mainly for advanced age), with no significant advantage for younger women. However, for carriers of chromosomal translocations, third-generation can fundamentally avoid miscarriage, making its value irreplaceable.
Fees at reproductive centers in different cities in Georgia can vary by up to 20%. Large chain clinics in Tbilisi (e.g., Beta Clinic, IVF Georgia) have relatively transparent pricing, while smaller clinics may have hidden fees. It is recommended to obtain detailed quotes in Chinese and English from 2-3 hospitals for comparison.

Case scenario analysis

Case 1 (suitable for third-generation): Ms. Zhang, 39 years old, AMH 1.2 ng/mL, had 2 miscarriages (embryo chromosomal abnormalities), normal karyotype. The doctor recommended PGT-A. She chose a third-generation package at a Georgian center for $14,000 (including medication and 1 transfer). She obtained 4 blastocysts; 2 were normal after biopsy, and the first transfer resulted in a successful pregnancy. Total cost was about $15,500 (including one year of freezing fees).

Case 2 (not suitable for third-generation): Ms. Li, 31 years old, AMH 3.7 ng/mL, husband with mild oligospermia, no history of miscarriage. The clinic recommended a third-generation package for $16,000. In reality, they had no genetic indications. After PGT-A, 4 out of 7 blastocysts were normal, but the transfer order was not significantly different from direct transfer. If they had chosen second-generation IVF (cost about $10,000), they could have saved $6,000 with a shorter cycle.

Risk reminders

When undergoing assisted reproduction in Georgia, be aware of:

Embryo biopsy carries a very low risk of damage (<1%), but the risk is relatively higher if blastocyst quality is poor;
PGT technology cannot screen for all genetic diseases; it can only detect known loci or chromosomal number/partial structural abnormalities;
In rare cases, misdiagnosis may occur (e.g., mosaic embryos being classified as abnormal and discarded). Choosing a center with a genetic counseling team can reduce this risk;
Medical dispute resolution mechanisms in Georgia are less developed than in Europe or the US. It is advisable to choose centers with international accreditation (e.g., JCI or ISO) and keep all contracts and payment receipts.

Suggestions for next steps

If you are considering IVF in Georgia, it is recommended to:

First complete a comprehensive fertility assessment for both partners (sex hormones, AMH, ultrasound, semen analysis, karyotype);
Clarify whether there are medical indications for third-generation IVF (genetic history, recurrent miscarriage, advanced age, etc.);
Collect quotes from 2-3 reputable Georgian institutions, paying special attention to whether they include medication, biopsy, freezing, and number of transfers;
When calculating total cost, include a budget for potential second ovarian stimulation or embryo accumulation (about $8,000 to $12,000);
Consult a genetic counselor or reproductive doctor in advance to avoid unnecessary PGT procedures.

Timing reminder

From consultation to starting the cycle, the process in Georgia usually takes 1-2 months of preparation (including document notarization, visa, preliminary tests). If choosing third-generation IVF, the biopsy and testing period adds about 2 weeks, making the overall timeline about 1 month longer than second-generation. It is recommended to start planning at least 3 months in advance.

This article is written based on general industry conditions. Specific costs are subject to the real-time quotes of medical institutions. Please consult a licensed physician and genetic counselor for assisted reproduction decisions.